BMC Endocrine Disorders | 2019

Glycated hemoglobin versus oral glucose tolerance test in the identification of subjects with prediabetes in Qatari population

 
 
 
 
 
 
 
 
 

Abstract


BackgroundSubjects with prediabetes are at increased risk of future T2DM and cardiovascular disease (CVD) compared to NGT individuals. The OGTT (FPG\u2009=\u2009100–125 and 2\u2009h-PG\u2009=\u2009140–199\u2009mg/dl) and HbA1c 5.7–6.4% have been used to diagnose subjects with prediabetes. In the present study, we compared the ability of the OGTT and HbA1c to identify Qatari subjects with prediabetes.MethodsFour hundred forty six subjects without a history of T2DM received 75-g OGTT and measurement of HbA1c. The incidence of prediabetes in this cohort according to OGTT criteria was compared to that of HbA1c criteria.ResultsThe agreement between the OGTT and HbA1c in identifying subjects with prediabetes in Qatari subjects was poor, though significant (k\u2009=\u2009015, p\u2009<\u20090.0001). Only 56% of participants had prediabetes or NGT according to OGTT and HbA1c. The disagreement between OGTT and HbA1c in diagnosing prediabetes was primarily due to low sensitivity of HbA1c. Moreover, subjects with prediabetes diagnosed with the OGTT have more severe metabolic profile than prediabetic subjects diagnosed with HbA1c. Lastly, more subjects with the metabolic syndrome were identified with OGTT (60%) criteria than with the HbA1c (49%), p\u2009<\u20090.0001.ConclusionThese results demonstrate subjects with prediabetes diagnosed with OGTT have more severe metabolic risk than those diagnosed with HbA1c, and more likely to have greater risk of progression to T2DM.

Volume 19
Pages None
DOI 10.1186/s12902-019-0412-1
Language English
Journal BMC Endocrine Disorders

Full Text